[PRNewswire] Sai Life Sciences, 유엔 글로벌 임팩트(UNGC)에 서명
(하이데라바드, 인도 2021년 8월 26일 PRNewswire=연합뉴스) 세계 굴지의 위탁 연구개발 제조업체(Contract Research, Development & Manufacturing Organization) [ https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ](CRO/CDMO)인 Sai Life Sciences가 세계 최대의 지속가능성 프로젝트 유엔 글로벌 임팩트(United Nations Global Compact, UNGC)에 서명했다고 오늘 발표했다. Sai Life Sciences는 UNGC 서명 기업으로서 인권, 노동, 환경 및 반부패에 관한 UNGC 10개 원칙을 채택하고, 기업의 책임감과 지속가능성을 향한 회사의 약속 [ https://www.sailife.com/commitment/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ]을 강화하기로 약속했다.
Sai Life Sciences CEO 겸 상무이사 Krishna Kanumuri는 이번 발표에 대해 "자사는 비전과 사업 성장을 추구하며, 자사의 사회, 환경 및 지배구조 책임을 끊임없이 통합한다"라며 "자사는 UNGC 10개 원칙 [ https://www.unglobalcompact.org/what-is-gc/mission/principles ]을 시행하고, 자사의 전략, 문화 및 일상 업무에 이를 적용하기로 약속했다"고 밝혔다. 이어 그는 "이를 통해 자사의 지속가능성 안건을 강화하는 데 기여하고, 지속가능한 개발 목표(Sustainable Development Goals)[ https://www.sailife.com/commitment/sustainability/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ](SDGs)를 향한 진전을 가속할 것"이라고 설명했다.
Sai Life Sciences는 지난 2년 동안 조직 변혁 프로젝트 'Sai Nxt'의 일환으로 지속가능성 안건을 발전시키는 데 상당한 투자를 단행했고, 그에 대한 진전을 이뤘다. 주목할 만한 주요사항 중 일부를 소개하면 다음과 같다.
- 인도에 본사를 둔 기업으로는 최초로 PSCI 회원사 [ https://www.sailife.com/sai-life-sciences-becomes-first-india-headquartered-company-to-join-pharmaceutical-supply-chain-initiative-psci/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ]로 가입했다.
- ACS Green Chemistry Institute Pharmaceutical Roundtable(ACS-GCIPR [https://www.sailife.com/sai-life-sciences-joins-the-acs-green-chemistry-institute-pharmaceutical-roundtable/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ])에 '준회원(Associate Member)'으로 가입했다.
- 2020년 GRI 체제에 맞춰 자사의 첫 번째 지속가능성 보고서(Sustainability Report)[ https://www.sailife.com/sai-life-sciences-releases-its-first-sustainability-report/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ]를 발표했다.
- 회사의 연구개발 및 제조 시설에 대해 ISO 14001:2015 및 ISO 45001:2018 [ https://www.sailife.com/sai-life-sciences-receives-iso-140012015-and-iso-450012018-certification/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] 인증을 받았다.
- 2020년 CII - Sohrabji Godrej Green Business Centre가 수여하는 명예로운 제21회 National Award for Excellence in Energy Management [ https://www.sailife.com/sai-life-sciences-receives-the-21st-national-award-for-excellence-in-energy-management-2020/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ]를 받았다.
- 2019년과 2020년에 Confederation of Indian Industry (CII) South 시상식에서 Excellence in EHS Practices [ https://www.sailife.com/sai-life-sciences-manufacturing-facility-achieves-5-star-rating-at-cii-sr-ehs-excellence-awards/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ]을 인정받아 별 5개 등급을 받았다.
Sai Life Sciences 소개
Sai Life Sciences는 복합 저분자 발견, 개발 및 상업화를 가속화 하기 위해 전 세계적으로 혁신업체 및 생명공학 기업과 협력하는 풀-서비스 CRO-CDMO [ https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] 다. 회사는 생명공학 기업뿐만 아니라 중소 제약사와 대규모 제약사까지 아우르는 다양한 고객에게 비용 효과적인 고품질 솔루션을 20년 이상 꾸준히 제공했다. 오늘날 Sai Life Sciences는 인도, 영국 및 미국에 위치한 자사 시설에서 2,200명이 넘는 직원을 고용하고 있다. Sai Life Sciences는 민간 기업이며, 국제적인 투자사인 TPG Capital과 HBM Healthcare Investments의 지원을 받는다. https://www.sailife.com
로고: https://mma.prnewswire.com/media/1044186/Sai_Life_Sciences_Logo.jpg
Sai Life Sciences
출처: Sai Life Sciences
Sai Life Sciences becomes a signatory of the United Nations Global Compact (UNGC)
HYDERABAD, India, Aug. 25, 2021 /PRNewswire/ -- Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization [https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] (CRO/ CDMO), today announced that it has become a signatory of the United Nations Global Compact (UNGC), the world's largest sustainability initiative. As a signatory, Sai Life Sciences has committed itself to adopting the Ten Principles of the UNGC on human rights, labour, environment and anti-corruption, reinforcing the company's commitment [https://www.sailife.com/commitment/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] to corporate responsibility and sustainability.
Making the announcement, Krishna Kanumuri, CEO & Managing Director said, "As we pursue our vision and business growth, we consciously integrate our social, environmental and governance responsibilities. We have committed ourselves to implement Ten Principles of the UNGC [https://www.unglobalcompact.org/what-is-gc/mission/principles ] and to make them part of the strategy, culture and day-to-day operations of our company. This will help us in strengthening our sustainability agenda and also accelerate our progress towards achieving our Sustainable Development Goals [https://www.sailife.com/commitment/sustainability/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] (SDGs)."
Over the past two years, Sai Life Sciences has made significant investments and progress in advancing its Sustainability agenda as part of its organizational transformation initiative, Sai Nxt. Some of the notable highlights:
- Became the first India-headquartered company to join the PSCI membership [https://www.sailife.com/sai-life-sciences-becomes-first-india-headquartered-company-to-join-pharmaceutical-supply-chain-initiative-psci/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ].
- Joined ACS Green Chemistry Institute Pharmaceutical Roundtable (ACS-GCIPR [https://www.sailife.com/sai-life-sciences-joins-the-acs-green-chemistry-institute-pharmaceutical-roundtable/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ]) as an 'Associate Member'.
- Released its first Sustainability Report [https://www.sailife.com/sai-life-sciences-releases-its-first-sustainability-report/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] in 2020 in line with the GRI framework
- Received the ISO 14001:2015 and ISO 45001:2018 [https://www.sailife.com/sai-life-sciences-receives-iso-140012015-and-iso-450012018-certification/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] certifications for its R&D and manufacturing sites.
- Won the prestigious 21st National Award for Excellence in Energy Management [https://www.sailife.com/sai-life-sciences-receives-the-21st-national-award-for-excellence-in-energy-management-2020/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] 2020 by CII - Sohrabji Godrej Green Business Centre
- Received 5-Star rating for Excellence in EHS Practices [https://www.sailife.com/sai-life-sciences-manufacturing-facility-achieves-5-star-rating-at-cii-sr-ehs-excellence-awards/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] at the Confederation of Indian Industry (CII) South awards 2019 and 2020.
About Sai Life Sciences
Sai Life Sciences is a full-service CRO-CDMO [https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] that works with innovator pharma and biotech companies globally, to accelerate the discovery, development and commercialisation of complex small molecules. For over two decades, Sai Life Sciences has consistently delivered high-quality, cost-effective solutions to its diverse customers spanning biotechs, small, mid and large pharma. Today, it has over 2200 employees across its facilities in India, UK and USA. Sai Life Sciences is privately held and backed by global investors, TPG Capital and HBM Healthcare Investments. https://www.sailife.com.
Logo: https://mma.prnewswire.com/media/1044186/Sai_Life_Sciences_Logo.jpg
Sai Life Sciences Logo
Source: Sai Life Sciences
[편집자 주] 본고는 자료 제공사에서 제공한 것으로, 연합뉴스는 내용에 대해 어떠한 편집도 하지 않았음을 밝혀 드립니다.
(끝)
출처 : PRNewswire 보도자료
(하이데라바드, 인도 2021년 8월 26일 PRNewswire=연합뉴스) 세계 굴지의 위탁 연구개발 제조업체(Contract Research, Development & Manufacturing Organization) [ https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ](CRO/CDMO)인 Sai Life Sciences가 세계 최대의 지속가능성 프로젝트 유엔 글로벌 임팩트(United Nations Global Compact, UNGC)에 서명했다고 오늘 발표했다. Sai Life Sciences는 UNGC 서명 기업으로서 인권, 노동, 환경 및 반부패에 관한 UNGC 10개 원칙을 채택하고, 기업의 책임감과 지속가능성을 향한 회사의 약속 [ https://www.sailife.com/commitment/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ]을 강화하기로 약속했다.
Sai Life Sciences CEO 겸 상무이사 Krishna Kanumuri는 이번 발표에 대해 "자사는 비전과 사업 성장을 추구하며, 자사의 사회, 환경 및 지배구조 책임을 끊임없이 통합한다"라며 "자사는 UNGC 10개 원칙 [ https://www.unglobalcompact.org/what-is-gc/mission/principles ]을 시행하고, 자사의 전략, 문화 및 일상 업무에 이를 적용하기로 약속했다"고 밝혔다. 이어 그는 "이를 통해 자사의 지속가능성 안건을 강화하는 데 기여하고, 지속가능한 개발 목표(Sustainable Development Goals)[ https://www.sailife.com/commitment/sustainability/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ](SDGs)를 향한 진전을 가속할 것"이라고 설명했다.
Sai Life Sciences는 지난 2년 동안 조직 변혁 프로젝트 'Sai Nxt'의 일환으로 지속가능성 안건을 발전시키는 데 상당한 투자를 단행했고, 그에 대한 진전을 이뤘다. 주목할 만한 주요사항 중 일부를 소개하면 다음과 같다.
- 인도에 본사를 둔 기업으로는 최초로 PSCI 회원사 [ https://www.sailife.com/sai-life-sciences-becomes-first-india-headquartered-company-to-join-pharmaceutical-supply-chain-initiative-psci/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ]로 가입했다.
- ACS Green Chemistry Institute Pharmaceutical Roundtable(ACS-GCIPR [https://www.sailife.com/sai-life-sciences-joins-the-acs-green-chemistry-institute-pharmaceutical-roundtable/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ])에 '준회원(Associate Member)'으로 가입했다.
- 2020년 GRI 체제에 맞춰 자사의 첫 번째 지속가능성 보고서(Sustainability Report)[ https://www.sailife.com/sai-life-sciences-releases-its-first-sustainability-report/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ]를 발표했다.
- 회사의 연구개발 및 제조 시설에 대해 ISO 14001:2015 및 ISO 45001:2018 [ https://www.sailife.com/sai-life-sciences-receives-iso-140012015-and-iso-450012018-certification/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] 인증을 받았다.
- 2020년 CII - Sohrabji Godrej Green Business Centre가 수여하는 명예로운 제21회 National Award for Excellence in Energy Management [ https://www.sailife.com/sai-life-sciences-receives-the-21st-national-award-for-excellence-in-energy-management-2020/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ]를 받았다.
- 2019년과 2020년에 Confederation of Indian Industry (CII) South 시상식에서 Excellence in EHS Practices [ https://www.sailife.com/sai-life-sciences-manufacturing-facility-achieves-5-star-rating-at-cii-sr-ehs-excellence-awards/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ]을 인정받아 별 5개 등급을 받았다.
Sai Life Sciences 소개
Sai Life Sciences는 복합 저분자 발견, 개발 및 상업화를 가속화 하기 위해 전 세계적으로 혁신업체 및 생명공학 기업과 협력하는 풀-서비스 CRO-CDMO [ https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] 다. 회사는 생명공학 기업뿐만 아니라 중소 제약사와 대규모 제약사까지 아우르는 다양한 고객에게 비용 효과적인 고품질 솔루션을 20년 이상 꾸준히 제공했다. 오늘날 Sai Life Sciences는 인도, 영국 및 미국에 위치한 자사 시설에서 2,200명이 넘는 직원을 고용하고 있다. Sai Life Sciences는 민간 기업이며, 국제적인 투자사인 TPG Capital과 HBM Healthcare Investments의 지원을 받는다. https://www.sailife.com
로고: https://mma.prnewswire.com/media/1044186/Sai_Life_Sciences_Logo.jpg
Sai Life Sciences
출처: Sai Life Sciences
Sai Life Sciences becomes a signatory of the United Nations Global Compact (UNGC)
HYDERABAD, India, Aug. 25, 2021 /PRNewswire/ -- Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization [https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] (CRO/ CDMO), today announced that it has become a signatory of the United Nations Global Compact (UNGC), the world's largest sustainability initiative. As a signatory, Sai Life Sciences has committed itself to adopting the Ten Principles of the UNGC on human rights, labour, environment and anti-corruption, reinforcing the company's commitment [https://www.sailife.com/commitment/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] to corporate responsibility and sustainability.
Making the announcement, Krishna Kanumuri, CEO & Managing Director said, "As we pursue our vision and business growth, we consciously integrate our social, environmental and governance responsibilities. We have committed ourselves to implement Ten Principles of the UNGC [https://www.unglobalcompact.org/what-is-gc/mission/principles ] and to make them part of the strategy, culture and day-to-day operations of our company. This will help us in strengthening our sustainability agenda and also accelerate our progress towards achieving our Sustainable Development Goals [https://www.sailife.com/commitment/sustainability/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] (SDGs)."
Over the past two years, Sai Life Sciences has made significant investments and progress in advancing its Sustainability agenda as part of its organizational transformation initiative, Sai Nxt. Some of the notable highlights:
- Became the first India-headquartered company to join the PSCI membership [https://www.sailife.com/sai-life-sciences-becomes-first-india-headquartered-company-to-join-pharmaceutical-supply-chain-initiative-psci/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ].
- Joined ACS Green Chemistry Institute Pharmaceutical Roundtable (ACS-GCIPR [https://www.sailife.com/sai-life-sciences-joins-the-acs-green-chemistry-institute-pharmaceutical-roundtable/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ]) as an 'Associate Member'.
- Released its first Sustainability Report [https://www.sailife.com/sai-life-sciences-releases-its-first-sustainability-report/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] in 2020 in line with the GRI framework
- Received the ISO 14001:2015 and ISO 45001:2018 [https://www.sailife.com/sai-life-sciences-receives-iso-140012015-and-iso-450012018-certification/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] certifications for its R&D and manufacturing sites.
- Won the prestigious 21st National Award for Excellence in Energy Management [https://www.sailife.com/sai-life-sciences-receives-the-21st-national-award-for-excellence-in-energy-management-2020/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] 2020 by CII - Sohrabji Godrej Green Business Centre
- Received 5-Star rating for Excellence in EHS Practices [https://www.sailife.com/sai-life-sciences-manufacturing-facility-achieves-5-star-rating-at-cii-sr-ehs-excellence-awards/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] at the Confederation of Indian Industry (CII) South awards 2019 and 2020.
About Sai Life Sciences
Sai Life Sciences is a full-service CRO-CDMO [https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=ungc-signatory ] that works with innovator pharma and biotech companies globally, to accelerate the discovery, development and commercialisation of complex small molecules. For over two decades, Sai Life Sciences has consistently delivered high-quality, cost-effective solutions to its diverse customers spanning biotechs, small, mid and large pharma. Today, it has over 2200 employees across its facilities in India, UK and USA. Sai Life Sciences is privately held and backed by global investors, TPG Capital and HBM Healthcare Investments. https://www.sailife.com.
Logo: https://mma.prnewswire.com/media/1044186/Sai_Life_Sciences_Logo.jpg
Sai Life Sciences Logo
Source: Sai Life Sciences
[편집자 주] 본고는 자료 제공사에서 제공한 것으로, 연합뉴스는 내용에 대해 어떠한 편집도 하지 않았음을 밝혀 드립니다.
(끝)
출처 : PRNewswire 보도자료
